Correction to Impact of U.S. Support for Patent Waiver on Vaccine Makers Article
2021年5月8日 - 8:55AM
Dow Jones News
Moderna Inc. agreed to provide its Covid-19 vaccine to the Covax
initiative at Moderna's lowest-tiered price. "U.S. Support for
Patent Waiver Unlikely to Cost Covid-19 Vaccine Makers in Short
Term" at 3:04 p.m. ET, incorrectly said Moderna agreed to donate
the doses.
(END) Dow Jones Newswires
May 07, 2021 19:40 ET (23:40 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Pfizer (NYSE:PFE)
過去 株価チャート
から 3 2024 まで 4 2024
Pfizer (NYSE:PFE)
過去 株価チャート
から 4 2023 まで 4 2024